Summary Alterations in gut microbiota composition offer insights that may be relevant for several chronic conditions, including obesity. This study aimed to evaluate the effect of (2)-epigallocatechin gallate (EGCG) on the modulation of gut microbiota and biomarkers of colonic fermentation end-products in rats. Rats were fed an assigned diet of either a control diet, a 0.3% (w/w) EGCG diet, or a 0.6% (w/w) EGCG diet for 4 wk. Compared to the control group, the addition of 0.6% EGCG to the diet brought about a significant increase in the starch and protein contents in the feces collected in the fourth week of feeding, but the relative weights of abdominal adipose tissues of rats were inversely suppressed. Hostspecific bacterial community composition, as determined by terminal restriction fragment length polymorphism (T-RFLP) patterns for fecal 16S ribosomal RNA, showed a significant response in the reduced occupation of Clostridium spp. and an increased trend of Bacteroides by dietary supplementation with EGCG. The 0.6% EGCG diet also influenced the status of Bifidobacterium and Prevotella to a lesser extent. Interestingly, the cecum of rats fed the 0.6% EGCG diet contained lower levels of acetic and butyric acids, whereas EGCG had little influence on the cecal level of propionic acid. EGCG also reduced the cecal p-cresol concentration in a dose-dependent fashion. In conclusion, dietary EGCG affects the growth of certain species of gut microbiota in rats and is associated with the cecal pattern of short chain fatty acids which could be responsible for regulating energy metabolism in the body.
The human large intestine constitutes an ecologically complicated flora made up of more than 1,000 bacterial species (1) . Intestinal microbiota play an important role in metabolic, nutritional, physiological, and immunological processes in the human body (2) . The relationship between gut microbiota and the development of obesity, type 2 diabetes and cardiovascular diseases is becoming clearer (3, 4) . A balanced composition of gut microbiota confers benefits to the host, whereas microbial imbalances are associated with metabolically mediated disorders. Consequently, favoring the abundance of beneficial bacteria and restricting the growth of pathogenic bacteria in the gut have positive effects on host health. Shaping of individual microbiota may be influenced by age, disease, nationality and antibiotic use, and is also influenced by a series of complex and dynamic interactions with dietary components (5) . Insight into the potential effects of prebiotic and/or probiotic intervention on the gut microbiota can be gained (6) . It is well-recognized that prebiotics (e.g., resistant starch, nondigestible oligosaccharides, and sugar alcohols) resist hydrolysis by mammalian enzymes, but are fermented by intestinal bacteria to yield short chain fatty acids (SCFAs), mainly acetic, propionic and butyric acids, eventually stimulating the growth and/or activity of intestinal bacteria that are potentially associated with health (7) .
Polyphenols are constituents of human food, their main sources being fruits, vegetables, cereals, legume seeds, red wine, coffee, and tea. There is a consensus of opinion from review articles that certain doses of selected polyphenols influence microbial populations in the gut; certain bacterial groups can be expanded, and others can be inhibited (8) (9) (10) . Furthermore, the intake of polyphenols and their derived products have significant effects on gut microbiota composition and probably their functional effects in mammalian tissues. Dolara et al. (11) found that treatment with red wine polyphenols lowered the levels of Clostridium spp. and increased the levels of Lactobacillus spp. in rats. A clinical trial by Queipo-Ortuño et al. (12) showed that daily consumption of red wine increased the number of selected gut microbiota such as Enterococcus, Prevotella, and Bacteroides, indicating a possible prebiotic benefit from dietary inclusion of polyphenol-rich foods. A randomized, controlled, double-blind, crossover intervention study by Tzounis et al. (13) also reported that the daily consumption of drinks rich in cocoa flavonols (494 mg/d) for 4 wk significantly affected the growth of select gut microflora in humans, and those microbial changes were paralleled by significant reductions in plasma triacylglycerol and C-reactive protein concen-trations. Green tea is also a rich source of polyphenols, known as tea catechins, consisting primarily of four components: (2)-epicatechin, (2)-epicatechin gallate, (2)-epigallocatechin (EGC) and (2)-epigallocatechin gallate (EGCG). EGCG is the main constituent of green tea catechins, accounting for about half of the total catechins (14) . The small-intestinal absorption of tea catechins is extremely poor (15) , suggesting that catechins could reach the large intestine, and be incorporated into the gut microbiota complex. The literature has demonstrated that the growth in vitro of certain pathogenic bacteria was significantly repressed by polyphenols in green tea (16, 17) . However, there are remarkably few studies investigating the in vivo influence of tea catechins on the composition and activity of the gut microbial community. Therefore, this study highlights the potential influence of dietary EGCG on gut microbiota ecology and fermentation end-products assessed by a rat model.
MATERIALS AND METHODS

Animals and diets.
Four-week-old male Wistar rats were purchased from Saitama Experimental Animals Supply Co., Ltd. (Saitama, Japan), and were housed individually in stainless steel cages at 23˚C in a room with an automatically controlled 12-h lighting cycle. The rats were fed a commercial chow (MF, Oriental Yeast Co., Ltd., Tokyo, Japan) and acclimated to the facility for 4 d before being fed the experimental diets. The rats were divided into 3 groups: control diet, 0.3% (w/w) EGCG diet, and 0.6% EGCG (w/w) diet (Table 1) . Highly purified EGCG, the purity of which was .94%, was purchased from DSM Nutrition Japan KK, (Tokyo, Japan). The rats had free access to tap water and the experimental diets for 4 wk. Food intake and body weight were determined thrice weekly. Feces were collected during the fourth week of the feeding period. At the end of the experiment, rats were sacrificed by drawing blood from the heart under diethyl ether anesthesia. The liver, abdominal adipose tissues (epididymis, perirenal, and mesenteric adipose) and cecum were immediately excised and weighed. This study was approved by the Animal Research Committee of the Tokyo Kasei Gakuin University, and all experimental procedures followed the guidelines for the care and use of experimental animals.
Fecal starch and protein analyses. Before analysis, dried feces samples were ground by a grinder mill. Starch content in feces was determined after hydrolysis with thermostable a-amylase and amyloglucosidase (Wako Pure Chemical Industries, Ltd., Osaka, Japan), followed by a determination of the released glucose using an enzymatic colorimetric assay kit (Glucose CIItest, Wako Pure Chemical Industries, Ltd.) (18) . Results were corrected to a starch basis by multiplying them by 0.9. Total fecal nitrogen was determined by Kjeldahl's method, and results were multiplied by 6.25 to calculate the amount of protein in the feces.
Analyses of SCFA in cecum content. Cecum contents were diluted 5-fold with distilled water, and ultrasonicated using a Branson homogenizer (model 250, Branson Ultrasonics Co., Danbury, CT). The SCFAs (acetic, propionic, and butyric acids) in the rat cecum homogenate were derivatized with 2-nitrophenylhydrazine hydrochloride in the presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride. The derivatives were separated with a 25036.0 mm I.D. C 8 reversed-phase column (YMC Co., Ltd., Kyoto, Japan), and were detected with a variable-wavelength monitor with the absorbance set at 400 nm (19) .
Analyses of phenol and p-cresol in cecum content. The concentrations of phenol and p-cresol in the cecum homogenate of each rat were also determined by HPLC coupled with a solid-phase extraction technique for sample cleanup. Two hundred microliters of 20% (w/v) trichloroacetic acid and 100 mL of 60 mg/mL p-chlorophenol as an internal standard were spiked to 0.5 g of the cecum homogenate. After centrifugation at 4˚C, 3,000 3g for 10 min, the resulting supernatant was applied to the disposal solid-phase extraction cartridges (Strata TM -X, 30 mg/mL, Phenomenex Inc., Torrance, CA). The cartridges were then washed with 1 mL of 20% (v/v) methanol, and eluted with 1 mL of methanol containing 0.1% (v/v) phosphoric acid. The eluate was applied to an HPLC system consisting of a reversedphase column (InertSustain C18, 15034.6 mm I.D., GL Science Inc., Tokyo, Japan) maintaining a temperature of 40˚C, a mobile phase (the mixture of acetonitrile, methanol and 0.1% phospholic acid (25 : 12.5 : 62.5, v/v/v)), and an electrochemical detector (Coulochem III, Model 5300, Dionex Co., Sunnyvale, CA) at the applied potentials of 1500 mV for electrode 1 and 1750 mV for electrode 2.
Fecal microbial composition analysis. Fecal samples of rats were analyzed by targeting the bacterial 16S rRNA genes examined using a terminal restriction fraction length polymorphism (T-RFLP) technique according to the procedure described by Nagashima et al. (20) . The fluorescently labeled primers 516f (5′-TGC-CAGCAGCCGCGGTA-3′) and 1510r (5′-GGTTACCTT- GTTACGACTT-3′) were used to amplify the 16S rRNA genes. The purified PCR products were digested with the restriction enzyme of BslI (New England BioLabs, Inc., Ipswich, MA). The length of the terminal restriction fragments was determined using an automated sequence analyzer (ABI PRISM 310 Genetic Analyzer, Applied Biosystems, Tokyo, Japan). The abundance of each terminal restriction fragment was determined based on fluorescence intensity and expressed as either peak area using software (GeneMapper ver. 4, Applied Biosystems). Fragment sizes are generally assigned to categories of operational taxonomic units (OTU). The OTU data were used to match the empirically determined fragment lengths to those predicted from various phylotypes in the database.
Determination of the copy number of fecal bacteria. The copy number of fecal bacteria was calculated from the standard curve of known bacterial copy number by quantitative real-time PCR of 16S rRNA gene using 341f (5′-CCTACGGGAGGCAGCAG-3′) and 534r (5′-ATTACC-GCGGCTGCTGG-3′) primers (21) . Amplification reactions were performed by a Rotor-Gene Q apparatus (Qiagen, Hilden, Germany) using SYBR Premix Ex Taq II (Tli RNaseH Plus, Takara Bio, Shiga, Japan).
Statistical analysis. All data are reported as mean6 SE. The bacterial copy numbers were converted into logarithm values before the statistical analysis. The significance of differences among the groups was determined by one-way ANOVA, and followed by Dunnett's test to compare the control group with each EGCG-treated group using a commercial software package (GraphPad Prism 5 for Windows, GraphPad Software, Inc., San Diego, CA). Differences were considered significant at p,0.05.
RESULTS
Body weight gain and organ weights
There were no differences among the groups in food intake or body weight gain during the 28-d experiment ( Table 2 ). The rats fed a 0.6% EGCG diet had lower relative organ weights of liver (p,0.01) and abdominal adipose tissues (the mass of mesenteric, perirenal and epididymal adipose tissues; p,0.05), compared with those fed a control diet. The 0.6% EGCG diet also significantly affected the relative weight of cecum content (p,0.01), whereas it did not differ between the control group and 
Starch and protein excretions into feces
The dry weight of feces collected during the fourth week of the feeding period in the 0.6% EGCG group was significantly higher than in the control group (p,0.01) ( Table 3) . Little starch was excreted in the feces of rats fed the control diet, whereas the feces of rats fed the 0.6% EGCG diet contained a significant amount of starch (p,0.01). However, there was no significant difference in starch excretion between the control group and the 0.3% EGCG group. Based on the gross starch that the rats consumed from their respective diets during the fecal collection period, the average rates of apparent digestibility of starch were estimated at 100.0%, 99.8% and 96.7% for the control diet, 0.3% EGCG diet and 0.6% EGCG diet, respectively. The 0.6% EGCG diet also brought about more protein excretion in feces than the control diet, significantly lowering the apparent digestibility of proteins as compared with the control group (p,0.01). Figure 1A summarizes the SCFA concentrations in the cecum contents of rats fed the different experimental diets. Feeding of the 0.6% EGCG diet resulted in significant decreases in the concentrations of acetic and butyric acids as compared to the control (both p,0.01), but the 0.3% EGCG diet did not show significant differences. The addition of EGCG to the diet, whether its level was 0.3% or 0.6%, had little influence on the concentration of propionic acid in the cecum contents.
SCFA, phenol and p-cresol concentrations in cecum contents
The concentrations of phenol and p-cresol in the cecum contents are shown in Fig. 1B . The diets supplemented with EGCG were associated with significant increases in cecal concentrations of phenol, with that of the 0.3% EGCG group being approximately 4-fold higher than the control group (p,0.05), and that of the 0.6% EGCG group being 8-fold higher (p,0.01). Contrastingly, cecal concentrations of p-cresol were decreased by the addition of EGCG to the diets. The cecal concentration of p-cresol in the 0.6% EGCG group was maintained at a far lower level than that of the control group (p,0.05).
Effect of EGCG on fecal microbiota
Changes in the numbers of 16S rRNA gene copies and the bacterial balance of fecal samples from 5 randomly selected rats of each group, collected during the fourth week of feedings, are shown in Table 4 . There was no significant difference in the numbers of 16S rRNA gene copies of fecal bacteria among the groups. However, T-RFLP analysis of the fecal microbiota revealed significant changes in fecal bacterial community structure. Remarkable alteration was found in the occupation ratios of bacterial genera Clostridium and Bacteroides. Dietary supplementation of EGCG resulted in a significant decrease in the ratio of Clostridium spp. in the fecal microbiota as compared to the control group (p,0.01 in both the 0.3% and 0.6% EGCG groups). Those bacteria were almost completely eliminated by adding EGCG at 0.6% to the diet. Contrastingly, there was a trend of variation resulting from increasing the Bacteroides balance. Treatment with a high level of EGCG affected the status of Bifidobacterium and Prevotella to a lesser extent-they had undetectable levels in all fecal samples as assessed by the T-RFLP determination.
DISCUSSION
Studies have provided insight into the biotransformation of polyphenols by intestinal bacteria, including an understanding of the tentative catabolic pathways in relation to the identification of bacteria having the ability to catabolize these kinds of polyphenols (22) (23) (24) . In recent years there has been a renewal of interest in the impact of polyphenolic components of common foods on gut microbial ecology, in accordance with the emerging consensus that the gut microbiota may play a crucial role in the potential health benefits of dietary polyphenols. To date, some in vitro studies examining the effect of tea catechins on intestinal microbiota have been reported (16, 17) . The present study aimed to evaluate the in vivo effect of EGCG, the most abundant polyphenol in green tea, on the gut microbial composition of rats. In addition, on the grounds that certain types of intestinal bacteria inhabiting the host intestine produce fermentation end-products such as SCFAs and p-cresol, the physiological relevance of which is receiving increased attention for host health (25) (26) (27) , this study also examined the influence of these fermentation end-products at the cecum level. Table 3 shows that the feces of rats fed the 0.6% EGCG diet contained more starch than that of the control diet. Especially given that EGCG possesses the inhibitory activity for pancreatic a-amylase (18) , it is acceptable to assume that appreciable amounts of undigested starch flowed into the large intestine, and were excreted in the feces. It is fair to say that dietary starch that reaches the large intestine could be a potential source of fermentable substrate for anaerobic bacteria, consequently leading to the production of SCFAs. Proteins and peptides increasingly contribute to SCFA production as food residues pass through the bowel. Although significant amounts of starch and proteins must have flowed through the large intestine of rats fed the 0.6% EGCG diet, the concentrations of acetic acid and butyric acid in the cecum contents were significantly low compared to the control group. Those of propionic acid, however, remained at the same level (Fig. 1A) . Formation of SCFAs by intestinal bacteria is regulated by many different environmental, dietary and microbiological factors (28) . Briefly, substrate availability, bacterial species composition of the microbiota, and intestinal transit time largely determine the amounts and types of SCFA that are produced in individuals. It is recognized that the majority of acetic acids originate from microbial breakdown of complex carbohydrates as food residues with the genera of Bifidobacterium, Bacteroides, Eubacterium, Clostridium and other anaerobic Gram-positive cocci in the gut. Furthermore, the genus of Bacteroides converts carbohydrates mainly into propionic acid, and Eubacterium and Clostridium convert carbohydrates into butyric acid (29) .
In this study, without a significant change in fecal bacteria numbers, the occupation ratio of Clostridium spp. among the total fecal microbiota was reduced by treatment with EGCG in the diets (Table 4) . Involvement of the decreased balance of Clostridium spp. in the 0.6% EGCG group may help account for significant decreases in cecal concentrations, both in acetic acid and butyric acid. On the other hand, feeding the 0.3% EGCG diet did not bring about significant influences in cecal levels of every SCFA. A previous paper by van't Slot and Humpf (23) documented that the ester bond of EGCG was rapidly cleaved when EGCG was incubated with cecum suspension of pigs, and the liberated EGC and gallic acid underwent further microbial degradation. Premising that the antimicrobial activity shown by tea catechins is mainly due to EGCG, the contributions of molecules in non-gallated forms to modify gut microbiota composition may be limited. Not only should the predicted threshold value at which EGCG can directly influence the intestinal bacteria be understood, but the nature of the degradation process for EGCG and the functionality of its metabolites in the gut are of importance.
Phenol and p-cresol are anaerobic degradation endproducts of tyrosine from the intestinal bacteria. Phenol is produced by the aerobic, and p-cresol by the anaerobic organisms in the gut (26) . It is known that p-cresol may be a uremic toxin, playing a role in the immunodeficiency of uremia by depressing phagocyte functional capacity (27) . The present study showed that feeding the 0.6% EGCG diet brought about a significant reduction in the cecal level of p-cresol. This could be explained by the modulation of microbial composition in the gut by treatment with EGCG. However, this study also demonstrated that the cecal concentrations of phenol were increased by treatment with EGCG in a dose-dependent manner. As mentioned before, EGCG first undergoes a hydrolysis process to yield EGC and gallic acid by intestinal bacteria, and the resulting gallic acid is further metabolized to yield phenol (30) . In view of this, the increased concentration of phenol in the cecum contents may be attributed to the microbial catabolism of EGCG.
A great deal of attention has been paid to the potential roles of gut microbiota in the development of obesity. Comparison of the gut microbiota of genetically obese mice and lean mice made it evident that obesity is associated with changes in the relative abundance of two bacterial phyla (31) . Briefly, the gut microbiota of obese mice includes fewer Bacteroidetes and correspondingly more Firmicutes than that of their lean counterparts. Furthermore, the cecum of obese mice has an increased concentration of the major fermentation end-products: acetic and butyric acids. Evidence suggests that the composition of the gut microbiota and its metabolic activities facilitate the extraction of energy from ingested dietary components, leading to accumulated energy in host adipose tissue for later use. It is widely recognized that tea catechins may have favorable effects on body composition in humans. In a 12-wk study of subjects whose body mass index was .22.5 kg/ m 2 , consumption of a higher dose (443.3 mg/d) of tea catechins compared with a lower dose (41.1 mg/d) was associated with significantly greater reductions in body weight, body fat, and visceral fat area (32) . Mechanistic studies using animal models focused on the anti-obesity attributes of tea catechins to inhibit lipid absorption (33) and alter the expression of genes involved in energy expenditure (34) . The results of this study demonstrated that relative weights of abdominal adipose tissues of rats fed the 0.6% EGCG diet were suppressed as compared to the control, providing the assumption that modulation of the bacteria inhabiting the intestine by EGCG may be of relevance for its anti-obesity effect. The outcome that treatment with EGCG resulted in a significant reduction of total SCFA amount in the cecum contents of rats might also support this assumption. However, further investigation is warranted to elucidate the specific effects of EGCG on the beneficial roles attributed to EGCG-microbiota interactions in the gut, particularly in relation to its preventive effect for obesity.
